The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback